跳至主要内容
临床试验/NCT00248690
NCT00248690已完成不适用

Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2005年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
2
主要终点
All cause mortality and neurological outcome

研究概览

简要总结

The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.

详细描述

In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological outcome after 3 and 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subarachnoid hemorrhage, acute
  • Intracerebral pressure monitoring device inserted

排除标准

  • No intracranial pressure monitoring
  • Age < 18 years

结局指标

主要结局

All cause mortality and neurological outcome

时间窗: 3 and 12 months

次要结局

  • Length of stay (ICU, hospital); complications; effect of treatment modalities on mean ICP, CPP, ICP mean wave amplitude.(Hospital stay)

研究者

发起方
Oslo University Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验